Marco M |
Opportunistic infections in Vancouver. |
1996 |
GMHC Treat Issues |
pmid:11363841
|
|
Azithromycin effective in preventing MAC. |
1996 |
AIDS Alert |
pmid:11363857
|
Schouten JT and Whittemore S |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). |
1996 |
STEP Perspect |
pmid:11364267
|
Wondrack L et al. |
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849266
|
Hulten K et al. |
In-vitro activity of azithromycin in against intracellular Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:9182105
|
Lode H et al. |
Azithromycin--review of key chemical, pharmacokinetic and microbiological features. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818841
|
Girard AE et al. |
Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818842
|
Girard D et al. |
Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818843
|
Foulds G et al. |
The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818844
|
Vaudaux BP et al. |
Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818845
|
Pukander J and Rautianen M |
Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818846
|
Rodriguez AF |
An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818847
|
O'Doherty B |
An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818848
|
Müller O |
An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818849
|
Gris P |
Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818850
|
Zachariah J |
A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818851
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Meloni G and Meloni T |
Azithromycin vs. doxycycline for Mediterranean spotted fever. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933556
|
Jackson MA et al. |
Breakthrough sepsis in macrolide-resistant pneumococcal infection. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933560
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Waugh MA |
Azithromycin in gonorrhoea. |
1996 |
Int J STD AIDS |
pmid:8652723
|
Young LS |
Treatment and prophylaxis of Mycobacterium avium complex. |
1996 |
Int J STD AIDS |
pmid:8652724
|
Hoepelman IM |
Human cryptosporidiosis. |
1996 |
Int J STD AIDS |
pmid:8652725
|
McCutchan JA |
Azithromycin in the prophylaxis of opportunistic infections in AIDS. |
1996 |
Int J STD AIDS |
pmid:8652726
|
Ridgway GL |
Azithromycin in the management of Chlamydia trachomatis infections. |
1996 |
Int J STD AIDS |
pmid:8652727
|
Ballard RC et al. |
Treatment of chancroid with azithromycin. |
1996 |
Int J STD AIDS |
pmid:8652728
|
Bowden FJ et al. |
Pilot study of azithromycin in the treatment of genital donovanosis. |
1996 |
Genitourin Med |
pmid:8655160
|
Kohl PK et al. |
Gonorrhoea: single-dose oral treatment. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743257
|
Nickel P and Näher H |
Nongonococcal urethritis. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743259
|
Johnson RB |
Azithromycin. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743269
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Jaruratanasirikul S et al. |
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851625
|
Bedos JP and Veber B |
[Lower respiratory infections: predictive factors of therapeutic response]. |
1996 |
Rev Pneumol Clin |
pmid:9033917
|
Zuck P |
[Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis]. |
1996 |
Rev Pneumol Clin |
pmid:9033919
|
Magid D et al. |
Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. |
1996 |
Ann. Intern. Med. |
pmid:8554247
|
Genç M and Mårdh A |
A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. |
1996 |
Ann. Intern. Med. |
pmid:7503471
|
Roord JJ et al. |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124837
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Yeates RA et al. |
Interaction between midazolam and clarithromycin: comparison with azithromycin. |
1996 |
Int J Clin Pharmacol Ther |
pmid:8880291
|
Dunn CJ and Barradell LB |
Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. |
1996 |
Drugs |
pmid:8882383
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Keysary A et al. |
The in-vitro anti-rickettsial activity of macrolides. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937968
|
Mein J et al. |
Donovanosis: sequelae of severe disease and successful azithromycin treatment. |
1996 |
Int J STD AIDS |
pmid:8940677
|
Hoque S et al. |
Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8941608
|
Wiselka MJ et al. |
Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. |
1996 |
J. Infect. |
pmid:8945715
|
Gómez E et al. |
Interaction between azithromycin and cyclosporin? |
1996 |
Nephron |
pmid:8856287
|